Skip to content

Clinical trials

Phase 3 Multiple Myeloma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 3 Country / region: China Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20122
20131
20153
20162
20175
20181
20192
20204
20216
20229
20233
20247
20256
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting20
Active, not recruiting17
Completed13
Unknown status7
Not yet recruiting3
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC11
GlaxoSmithKline5
Celgene4
Pfizer4
AbbVie2
Amgen2
Bristol-Myers Squibb2
Qilu Pharmaceutical Co., Ltd.2
Sanofi2
The Affiliated People's Hospital of Ningbo University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma62
Recurrence12
Cancer Pain1
Hematologic Diseases1
Neoplasms1
Neoplasms, Plasma Cell1
Peripheral Nervous System Diseases1
Venous Thromboembolism1

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.